Experts note that severely obese people die, on average, eight to 10 years sooner than people who are at normal weight, with every 15 extra kilograms of body weight increasing risk of early death by around 30 percent. Obesity, as defined by the World Health Organization, is a body mass index of more than 30, and it is estimated that this population is responsible for between 1 and 3 percent of total health spending in most countries; and for as much as 5 to 10 percent in the United States. Obesity has been shown to be a risk factor for a number of conditions, among them: coronary heart disease, type 2 diabetes, hypertension, stroke, gallbladder disease, and certain types of cancer
A Mandate for Medical Education Focused on Obesity. In light of the increasing prevalence of this problem, and the challenges in identifying treatment strategies for overweight and obese patients that will produce enduring weight loss, there is an urgent need for evidence-based education that physicians at the front lines of patient care can apply to achieve clinically meaningful weight loss in individuals who meet medical criteria for pharmacologic and/ or surgical intervention.
Against this backdrop, the purpose of this Science-to-Strategy, Best Practice Summit, Evolving Challenges and Emerging Treatment Paradigms for the Management of Obesity, is to discuss, present, and analyze the clinical implications of the latest therapeutic developments and emerging paradigms for effecting weight loss in patients at risk for complications associated with excessive weight.
Jointly Sponsored by CMEducation Resources, LLC and Ultimate Medical Academy
This CME activity is supported by an educational grant from Eisai, Inc.
You and your clinical colleagues are invited to attend a Science-to-Practice, CME Mega-Symposium
A Year 2014 Science-to-Strategy Update for the Primary Care, Endocrine, Diabetes, NP, and Related Clinical Specialist
Jointly Sponsored by
CMEducation Resources, LLC and Ultimate Medical Academy
Overview and Scope of Problem. From an internal medicine and primary care perspective, the need to risk stratify, assess, and provide outcome-effective management for overweight individuals and, especially, those who meet accepted clinical criteria for being obese, has never been greater.
Over the past 20 years, there has been a dramatic increase in obesity in the United States and rates remain high. In 2011, no state had a prevalence of obesity less than 20%. And 36 states had a prevalence of 25% or more; 12 of these states (Alabama, Arkansas, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Oklahoma, South Carolina, Tennessee, Texas, and West Virginia) had a prevalence of 30% or more.